top of page

Publications

Original Article

Neu antigen-negative variants can be generated after neu-specific antibody therapy in neu transgenic mice

Cancer Vaccines

2004

Authors:

Knutson, K.L., Almand, B., Dang, Y., Disis, M.L.

Journal:

Cancer Research

Volume:

64(3)

Page:

1146-51

Original Article

Humoral epitope-spreading following immunization with a HER-2/neu peptide based vaccine in cancer patients

Cancer Vaccines

2004

Authors:

Disis, M.L., Goodell, V., Schiffman, K., and Knutson, K.L

Journal:

Journal of Clinical Oncology

Volume:

24(5)

Page:

571-8

Original Article

Effect of dose on immune response in patients vaccinated with an her-2/neu intracellular domain protein--based vaccine

Cancer Vaccines

2004

Authors:

Disis ML, Schiffman K, Guthrie K, Salazar LG, Knutson KL, Gooddell V, dela Rosa C, Cheever MA

Journal:

Journal of Clinical Oncology

Volume:

22(10)

Page:

1916-25

Review Article

Peptide-based vaccines in breast cancer

Cancer Vaccines

2004

Authors:

Disis ML, Salazar LG, and Knutson KL

Journal:

Breast Disease

Volume:

20

Page:

3-11

Original Article

Plasmid-based vaccines encoding rat neu and immune stimulatory molecules can elicit rat neu-specific immunity

Cancer Vaccines

2003

Authors:

Disis, M.L., Scholler, N., Dahlin, A., Pullman, J., Knutson, K., Hellstrom, K. and Hellstrom, I

Journal:

Molecular Cancer Therapeutics

Volume:

2(10)

Page:

995-1002

Original Article

Identification of tumor-specific antibodies in patients with breast cancer vaccinated with gene-modified allogeneic tumor cells

Cancer Vaccines

2003

Authors:

Dols A, Meijer SL, Hu HM, Goodell V, Disis ML, von Mensdorff-Pouilly S, Verheijen R, Alvord WG, Smith J, Urba WJ and Fox BA

Journal:

Journal of Immunotherapy

Volume:

26(2)

Page:

163-70

Review Article

HER-2/neu vaccines

Cancer Vaccines

2003

Authors:

Disis ML, Schiffman K, Salazar LG, Almand B, and Knutson KL

Journal:

Cancer Chemotherapy and Biological Response Modifiers Annual

Volume:

21

Page:

275-85

Original Article

Immunization of cancer patients with HER-2/neu-derived peptides demonstrating high-affinity binding to multiple class II alleles

Cancer Vaccines

2003

Authors:

Salazar, L., Fikes, J., Southwood, S., Ishioka, G., Knutson, K., Gooley, T., Schiffman, K. and Disis, M.L

Journal:

Clinical Cancer Research

Volume:

9(15)

Page:

5559-65

Original Article

Pilot study of an HLA-A2 peptide vaccine using flt3 ligand as a systemic vaccine adjuvant

Cancer Vaccines

2003

Authors:

McNeel DG, Knutson KL, Schiffman K, Davis D, Caron D and Disis ML

Journal:

Journal of Clinical Immunology

Volume:

23(1)

Page:

62-72

Review Article

Immunotherapy of glioblastoma multiforme

Cancer Vaccines

2003

Authors:

Knutson KL, Salazar L, Schiffman K, and Disis ML

Journal:

Expert Review of Neurotherapeutics

Volume:

3(4)

Page:

511-23

bottom of page